# Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights
Canonical URL: https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-reports-first-quarter-2026-financial-results-and-operational-highlights
Ticker: TNXP
Company: Tonix Pharmaceuticals
Source: Tonix Pharmaceuticals
Published: 2026-05-11 20:30 EST
Original Source URL: https://ir.tonixpharma.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-05-28 20:30 EST — [Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting](https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-presented-retrospective-u-s-real-world-claims-analysis-of-opioid-use-in-patients-with-fibromyalgia-at-the-2026-american-society-of-clinical-psychopharmacology-ascp-annual-meeting) — Source: Tonix Pharmaceuticals
- 2026-05-27 11:00 EST — [Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology](https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-announces-publication-of-phase-1-clinical-data-of-tnx-1500-an-fc-modified-anti-cd40l-cd154-monoclonal-antibody-in-the-peer-reviewed-journal-of-clinical-immunology) — Source: Tonix Pharmaceuticals
- 2026-05-26 11:00 EST — [Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at The Professional Society for Health Economics and Outcomes Research (ISPOR) 2026 Annual Meeting](https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-presented-retrospective-u-s-real-world-claims-analysis-characterizing-patients-with-fibromyalgia-at-the-professional-society-for-health-economics-and-outcomes-research-ispor-2026-annual-meeting) — Source: Tonix Pharmaceuticals
- 2026-05-14 11:00 EST — [Tonix Pharmaceuticals to Present Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at ISPOR 2026](https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-to-present-retrospective-u-s-real-world-claims-analysis-characterizing-patients-with-fibromyalgia-at-ispor-2026) — Source: Tonix Pharmaceuticals
- 2026-05-12 20:30 EST — [Tonix Pharmaceuticals to Participate in Two Investor Conferences in May](https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-to-participate-in-two-investor-conferences-in-may) — Source: Tonix Pharmaceuticals
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)